130 related articles for article (PubMed ID: 34369368)
61. Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naïve patients with spondyloarthritis.
Lindström U; Glintborg B; Di Giuseppe D; Nordström D; Aarrestad Provan S; Gudbjornsson B; Askling J; Lund Hetland M; Aaltonen K; Krogh NS; Geirsson AJ; Jacobsson LTH
RMD Open; 2019; 5(2):e001079. PubMed ID: 31749988
[TBL] [Abstract][Full Text] [Related]
62. Biological therapies in the spondyloarthritides--the current state.
Braun J; Sieper J
Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
[TBL] [Abstract][Full Text] [Related]
63. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
Solomon DH; Love TJ; Canning C; Schneeweiss S
Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807
[TBL] [Abstract][Full Text] [Related]
64. Clinical and Imaging Signs of Spondyloarthritis in First-Degree Relatives of HLA-B27-Positive Ankylosing Spondylitis Patients: The Pre-Spondyloarthritis (Pre-SpA) Cohort Study.
Turina MC; de Winter JJ; Paramarta JE; Gamala M; Yeremenko N; Nabibux MN; Landewé R; Baeten DL
Arthritis Rheumatol; 2016 Oct; 68(10):2444-55. PubMed ID: 27214232
[TBL] [Abstract][Full Text] [Related]
65. Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.
Menegatti S; Bianchi E; Rogge L
Front Immunol; 2019; 10():382. PubMed ID: 30941119
[TBL] [Abstract][Full Text] [Related]
66. Heel pain in spondyloarthritis: results of a cross-sectional study of 275 patients.
Koumakis E; Gossec L; Elhai M; Burki V; Durnez A; Fabreguet I; Meyer M; Payet J; Roure F; Paternotte S; Dougados M
Clin Exp Rheumatol; 2012; 30(4):487-91. PubMed ID: 22510579
[TBL] [Abstract][Full Text] [Related]
67. Does evaluation of the ligamentous compartment enhance diagnostic utility of sacroiliac joint MRI in axial spondyloarthritis?
Weber U; Maksymowych WP; Chan SM; Rufibach K; Pedersen SJ; Zhao Z; Zubler V; Østergaard M; Lambert RG
Arthritis Res Ther; 2015 Sep; 17(1):246. PubMed ID: 26363915
[TBL] [Abstract][Full Text] [Related]
68. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
[TBL] [Abstract][Full Text] [Related]
69. Psoriasis is an independent risk factor for entheseal damage in axial spondyloarthritis.
Solmaz D; Bakirci S; Jibri Z; Sampaio M; Karsh J; Aydin SZ
Semin Arthritis Rheum; 2020 Feb; 50(1):42-47. PubMed ID: 31324469
[TBL] [Abstract][Full Text] [Related]
70. [Ocular involvement in spondylarthritis--new mechanisms, new therapies].
Itulescu TC; Alexandrescu C; Voinea LM
Oftalmologia; 2014; 58(1):27-35. PubMed ID: 25145120
[TBL] [Abstract][Full Text] [Related]
71. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27.
Bakland G; Alsing R; Singh K; Nossent JC
Arthritis Care Res (Hoboken); 2013 Mar; 65(3):448-53. PubMed ID: 22833469
[TBL] [Abstract][Full Text] [Related]
72. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.
Stolwijk C; Pierik M; Landewé R; Masclee A; van Tubergen A
Can J Gastroenterol; 2013 Apr; 27(4):199-205. PubMed ID: 23616957
[TBL] [Abstract][Full Text] [Related]
73. Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis.
de Winter JJ; Paramarta JE; de Jong HM; van de Sande MG; Baeten DL
RMD Open; 2019; 5(1):e000802. PubMed ID: 30713720
[TBL] [Abstract][Full Text] [Related]
74. The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic.
Poddubnyy D; Brandt H; Vahldiek J; Spiller I; Song IH; Rudwaleit M; Sieper J
Ann Rheum Dis; 2012 Dec; 71(12):1998-2001. PubMed ID: 22915622
[TBL] [Abstract][Full Text] [Related]
75. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
Pombo-Suarez M; Sanchez-Piedra C; Garcia-Magallón B; Pérez-Gómez A; Manrique-Arija S; Martín-Doménech R; Colazo M; Campos C; Campos J; Del Pino-Montes J; Arteaga MJ; Cea-Calvo L; Díaz-González F; Gómez-Reino JJ
Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
[TBL] [Abstract][Full Text] [Related]
76. Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis.
Cruz-Machado AR; Rodrigues-Manica S; Silva JL; Alho I; Coelho C; Duarte J; Florêncio C; Pimentel-Santos FM; Tavares-Costa J; Vieira-Sousa E
Rheumatology (Oxford); 2020 Nov; 59(11):3158-3171. PubMed ID: 32696064
[TBL] [Abstract][Full Text] [Related]
77. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study.
Sieper J; Srinivasan S; Zamani O; Mielants H; Choquette D; Pavelka K; Loft AG; Géher P; Danda D; Reitblat T; Cantini F; Ancuta C; Erdes S; Raffayová H; Keat A; Gaston JS; Praprotnik S; Vastesaeger N
Ann Rheum Dis; 2013 Oct; 72(10):1621-7. PubMed ID: 23065731
[TBL] [Abstract][Full Text] [Related]
78. High prevalence of spondyloarthritis in sarcoidosis patients with chronic back pain.
Sigaux J; Semerano L; Nasrallah T; Nunes H; Bouvry D; Valeyre D; Boissier MC; Saidenberg-Kermanac'h N
Semin Arthritis Rheum; 2019 Oct; 49(2):246-250. PubMed ID: 31138443
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care.
Poddubnyy D; Vahldiek J; Spiller I; Buss B; Listing J; Rudwaleit M; Sieper J
J Rheumatol; 2011 Nov; 38(11):2452-60. PubMed ID: 21921100
[TBL] [Abstract][Full Text] [Related]
80. Adverse effects of TNF inhibitors in SpA: are they different from RA?
Sampaio-Barros PD; van der Horst-Bruinsma IE
Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):747-63. PubMed ID: 25488782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
